The role of noncoding RNAs in rare gynecological cancers
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
DOI: 10.1016/j.bbcan.2025.189362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Le Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, Inner Mongolia, China. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, RNA, Untranslated, Biomarkers, Tumor, Rare Diseases. Die Arbeit nennt 167 Literaturangaben. Gefördert von: Doctoral Scientific Research Foundation of the Affiliated Hospital of Inner Mongolia Medical University, Natural Science Foundation of Inner Mongolia Autonomous Region, Cultivation Program for National Natural Science Foundation of the Affiliated Hospital of Inner Mongolia Medical University.
Abstract (Originalsprache)
Gynecological cancers are cancers that begin in the female reproductive organs. Gynecological cancer is the second most common cancer type among women and has become a global health burden for the female population. More than 50 % of all gynecological cancers can be defined as rare cancers. Three main types of noncoding RNAs (ncRNAs), namely, microRNAs (miRNAs), long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs), play crucial regulatory roles in physiological and pathological processes. Increasing evidence has revealed that ncRNAs closely participate in gynecological cancers. In this review, we focus on the role of ncRNAs in rare gynecological cancers. We first introduce the definitions, classifications, epidemiological characteristics, prognoses and treatments of rare gynecological cancers. Next, we summarize the differentially expressed ncRNAs and the molecular mechanisms underlying ncRNA connections to tumorigenesis, metastasis, chemoresistance, and recurrence. Finally, we highlight the potential applications of ncRNAs as diagnostic and prognostic biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, Inner Mongolia, China.
- Center for Reproductive Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, Inner Mongolia, China. Electronic address: 429398690@qq.com.
Förderung
- Doctoral Scientific Research Foundation of the Affiliated Hospital of Inner Mongolia Medical University
- Natural Science Foundation of Inner Mongolia Autonomous Region
- Cultivation Program for National Natural Science Foundation of the Affiliated Hospital of Inner Mongolia Medical University
- Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region
- Startup Foundation for Advanced Talents of Inner Mongolia
- Inner Mongolia Medical University Affiliated Hospital Talent Training Project-Sailing Series
- General Program of Natural Science Foundation of Inner Mongolia
- Inner Mongolia Medical University
Zitieren
APA
Zhang, L., Chen, X., Zhang, Y., Wang, S., & Sun, H. (2025). The role of noncoding RNAs in rare gynecological cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189362
Vancouver
Zhang L, Chen X, Zhang Y, Wang S, Sun H. The role of noncoding RNAs in rare gynecological cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189362
BibTeX
@article{Zhang2025,
author = {Zhang, Le and Chen, Xiujuan and Zhang, Yanbing and Wang, Saren and Sun, Hailong},
title = {The role of noncoding RNAs in rare gynecological cancers},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
doi = {10.1016/j.bbcan.2025.189362}
}
EUVIMED